Early transcriptional profiles in huntingtin-induced striatal cells by microarray analyses

Human Molecular Genetics

Volumn 11, Issue 17, 2002, Pages 1953-1965

  Sipione, Simonetta ^a   Rigamonti, Dorotea ^a   Valenza, Marta ^a   Zuccato, Chiara ^a   Conti, Luciano ^a   Pritchard, Joel ^b   Kooperberg, Charles ^b   Olson, James M ^b   Cattaneo, Elena ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; HUNTINGTIN; MUTANT PROTEIN; CHOLESTEROL; FATTY ACID; MESSENGER RNA; PEPTIDE; POLYGLUTAMINE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BRAIN CELL; CELL CLONING; CELL DEATH; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CORPUS STRIATUM; DNA MICROARRAY; FATTY ACID METABOLISM; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUNTINGTON CHOREA; INDUCED MUTATION; LIPID METABOLISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN AGGREGATION; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSPORT VESICLE; UNINDEXED SEQUENCE; ANIMAL; CELL CULTURE; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MUTATION; NORTHERN BLOTTING; PRENATAL DEVELOPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRINUCLEOTIDE REPEAT;

ANIMAL; BASE SEQUENCE; BLOTTING, NORTHERN; CELLS, CULTURED; CHOLESTEROL; CORPUS STRIATUM; FATTY ACIDS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUNTINGTON DISEASE; IMMUNOENZYME TECHNIQUES; MOLECULAR SEQUENCE DATA; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRINUCLEOTIDE REPEAT EXPANSION; ANIMALS; HUMANS;

ANIMALIA;

EID: 0037101839     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome
2. Differential loss of striatal projection neurons in Huntington disease
3. Wild-type huntingtin protects from apoptosis upstream of caspase-3
4. Loss of normal huntingtin function: New developments in Huntington's Disease research
5. Loss of Huntingtin-mediated BDNF gene transcription in Huntington's disease
6. Polyglutamine diseases: Protein cleavage and aggregation
7. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
8. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
9. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract
10. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells
11. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis
12. Transcriptional activation modulated by homopolymeric glutamine and proline stretches
13. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
14. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
15. Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription
16. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity
17. The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: Neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis
18. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease
19. Transcriptional dysregulation in Huntington's disease
20. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
21. Therapeutic opportunities in polyglutamine disease
22. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
23. Evaluating test-statistics to select interesting genes
24. DNA microarrays identification of primary and secondary target genes regulated by p53
25. SAGE transcript profiles for p53-dependent growth regulation
26. Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches
27. Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines
28. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays
29. Cellular transformation by SV40 large T antigen: Interaction with host proteins
30. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease
31. Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome
32. A critical review of brain cholesterol metabolism
33. Brain lipoprotein metabolism and its relation to neurodegenerative disease
34. Cholesterol metabolism in the brain
35. CNS synaptogenesis promoted by glia-derived cholesterol
36. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles
37. SNAREs are concentrated in cholesterol-dependent clusters that define docking and fusion sites for exocytosis
38. Cholesterol-dependent modulation of dendrite outgrowth and microtubule stability in cultured neurons
39. Wild-type and mutant huntingtins function in vesicle trafficking in the secretary and endocytic pathways
40. Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy
41. Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity
42. Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease
43. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
44. Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington's disease
45. Free fatty acids and pathogenesis of type 2 diabetes mellitus
46. Abnormalities in the functioning of adipocytes from R6/2 mice that are transgenic for the Huntington's disease mutation
47. Diabetes mellitus in Huntington disease
48. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease
49. Body weight and dietary factors in Huntington's disease patients compared with matched controls
50. Higher sedentary energy expenditure in patients with Huntington's disease
51. Sterol regulatory element-binding proteins (SREBPs): Key regulators of nutritional homeostasis and insulin action
52. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ
53. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis
54. PPARα and PPARΥ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene
55. Cholesterol biosynthesis from lanosterol. A concerted role for Sp1 and NF-Y-binding sites for sterol-mediated regulation of rat 7-dehydrocholesterol reductase gene expression
56. Transcriptional regulation of the murine acetyl-CoA synthetase 1 gene through multiple clustered binding sites for sterol regulatory element-binding proteins and a single neighboring site for Sp1
57. Sp1 and TAFTII130 transcriptional activity disrupted in early Huntington's disease
58. Interaction of Huntington disease protein with transcriptional activator Sp1
59. DNA microarrays identification of primary and secondary target genes regulated by p53
60. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays
61. Generation and characterization of embryonic striatal conditionally immortalized ST14A cells
62. The influence of huntingtin protein size on nuclear localization and cellular toxicity
63. A short term analysis of the behaviour of conditionally immortalized neuronal progenitors and primary neuroepithelial cells implanted into the fetal rat brain
64. Estimating confidence intervals for gene expression changes observed with oligonucleotide array